WASATCH ADVISORS INC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-08 1:11 pm Sale |
2024-03-08 | 13G | C4 Therapeutics, Inc. CCCC |
WASATCH ADVISORS INC | 5,516,718 8.000% |
-1,622,231 (-22.72%) |
Filing |
| 2024-02-09 1:04 pm Purchase |
2024-02-09 | 13G | C4 Therapeutics, Inc. CCCC |
WASATCH ADVISORS INC | 7,138,949 14.500% |
1,363,251 (+23.60%) |
Filing |
| 2023-02-08 3:42 pm Purchase |
2023-02-08 | 13G | C4 Therapeutics, Inc. CCCC |
WASATCH ADVISORS INC | 5,775,698 11.800% |
789,626 (+15.84%) |
Filing |
| 2022-06-06 1:31 pm Purchase |
2022-06-06 | 13G | C4 Therapeutics, Inc. CCCC |
WASATCH ADVISORS INC | 4,986,072 10.200% |
4,986,072 (New Position) |
Filing |